Inari Medical Inc.

79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM

Inari Medical Statistics

Share Statistics

Inari Medical has 58.56M shares outstanding. The number of shares has increased by 1.01% in one year.

Shares Outstanding 58.56M
Shares Change (YoY) 1.01%
Shares Change (QoQ) 0.48%
Owned by Institutions (%) 93.59%
Shares Floating 53.34M
Failed to Deliver (FTD) Shares 1
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 2.35M, so 4.01% of the outstanding shares have been sold short.

Short Interest 2.35M
Short % of Shares Out 4.01%
Short % of Float 4.65%
Short Ratio (days to cover) 0.54

Valuation Ratios

The PE ratio is undefined and the forward PE ratio is 304.2. Inari Medical's PEG ratio is undefined.

PE Ratio undefined
Forward PE 304.2
PS Ratio 7.47
Forward PS 4.2
PB Ratio 7.93
P/FCF Ratio undefined
PEG Ratio undefined
Financial Ratio History

Enterprise Valuation

Inari Medical has an Enterprise Value (EV) of 3.68B.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.09, with a Debt / Equity ratio of undefined.

Current Ratio 3.09
Quick Ratio 2.52
Debt / Equity undefined
Debt / EBITDA -
Debt / FCF -
Interest Coverage undefined

Financial Efficiency

Return on Equity is 0% and Return on Invested Capital is 1.09%.

Return on Equity 0%
Return on Assets 0%
Return on Invested Capital 1.09%
Revenue Per Employee $379.72K
Profits Per Employee $-1.26K
Employee Count 1,300
Asset Turnover 0.73
Inventory Turnover 1.38

Taxes

Income Tax 5.88M
Effective Tax Rate 1.39%

Stock Price Statistics

The stock price has increased by 41.87% in the last 52 weeks. The beta is 1.03, so Inari Medical's price volatility has been higher than the market average.

Beta 1.03
52-Week Price Change 41.87%
50-Day Moving Average 68.49
200-Day Moving Average 52.58
Relative Strength Index (RSI) 79.6
Average Volume (20 Days) 2.34M

Income Statement

In the last 12 months, Inari Medical had revenue of 493.63M and earned -1.64M in profits. Earnings per share was -0.03.

Revenue 493.63M
Gross Profit 434.56M
Operating Income -14.03M
Net Income -1.64M
EBITDA 15.19M
EBIT -14.03M
Earnings Per Share (EPS) -0.03
Full Income Statement

Balance Sheet

The company has 38.6M in cash and 32.05M in debt, giving a net cash position of 6.55M.

Cash & Cash Equivalents 38.6M
Total Debt 32.05M
Net Cash 6.55M
Retained Earnings -48.49M
Total Assets 697.24M
Working Capital 114.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 35.93M and capital expenditures -6.2M, giving a free cash flow of 29.73M.

Operating Cash Flow 35.93M
Capital Expenditures -6.2M
Free Cash Flow 29.73M
FCF Per Share 0.52
Full Cash Flow Statement

Margins

Gross margin is 88.03%, with operating and profit margins of -2.84% and -0.33%.

Gross Margin 88.03%
Operating Margin -2.84%
Pretax Margin 0.86%
Profit Margin -0.33%
EBITDA Margin 3.08%
EBIT Margin -2.84%
FCF Margin 6.02%

Dividends & Yields

NARI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -0.04%
FCF Yield 0.63%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NARI.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 11.23
Piotroski F-Score 2